12 West Capital Management LP / MRVI
12 West Capital Management LP’s Maravai Lifesciences Hldgs I Position
Does 12 West Capital Management LP own Maravai Lifesciences Hldgs I (MRVI)? Yes — 7.26M shares worth $21M (+3.47% of its 13F portfolio) as of Q1 2026, down from 8.92M shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
7.26M
% of Portfolio
+3.47%
Quarters Held
13
currently held
Position History MRVI
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.26M | $21M | +3.47% |
| Q4 2025 | 8.92M | $29M | +3.45% |
| Q3 2025 | 12.52M | $36M | +3.73% |
| Q2 2025 | 12.52M | $30M | +3.19% |
| Q1 2025 | 12.52M | $28M | +4.08% |
| Q4 2024 | 11.59M | $63M | +6.62% |
| Q3 2024 | 14.01M | $116M | +11.91% |
| Q2 2024 | 13.21M | $95M | +9.72% |
| Q1 2024 | 13.20M | $114M | +10.32% |
| Q4 2023 | 11.60M | $76M | +6.76% |
| Q3 2023 | 6.46M | $65M | +5.85% |
| Q2 2023 | 3.36M | $42M | +3.59% |
| Q1 2023 | 2.57M | $36M | +3.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 12 West Capital Management LP’s full portfolio or all institutional holders of MRVI.